Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Verdeca gets US FDA OK for anti-stress protein

The Verdeca joint venture between US agricultural biotechnology company Arcadia Biosciences (Davis, California) and Argentine soybean development consortium Bioceres (Rosario) has received notification from the US FDA that it has completed the early food safety evaluation (EFSE) process for the HAHB4 protein responsible for Verdeca's HB4 stress tolerance trait. Completion of this review is a major milestone in the development of commercial soybean seed products based on the trait as well as the development of HB4-based products in other crops, the companies point out. "Soybean seed products based on the HB4 stress tolerance trait are in the latter stages of development and completion of the EFSE process is a very strong and positive signal about safety," says Arcadia president and CEO Eric Rey. Last month, Arcadia, Bioceres and Brazilian company Tropical Melhoramento e Genética agreed to develop soybean varieties based on the HB4 trait, which was approved in Argentina in April.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts